Managing Spinal Muscular Atrophy in Adult Patients : Episode 13
Opinion
Video
Real-World Data for Risdiplam in Adult Patients with Spinal Muscular Atrophy
Panelists examine the available real-world data (RWD) on the use of risdiplam in adult patients with spinal muscular atrophy (SMA) from various studies conducted worldwide, discussing its potential efficacy and safety as a treatment option for adult SMA patients.
- Discuss real-world evidence for risdiplam in adult patients.
Related Videos
Related Content
